Shaanxi Meibang Pharmaceutical (605033)
Search documents
美邦股份:公司目前生产经营正常,无应披露而未披露的重大信息
Zheng Quan Ri Bao Wang· 2025-12-19 15:13
证券日报网讯12月19日,美邦股份(605033)在互动平台回答投资者提问时表示,公司目前生产经营正 常,无应披露而未披露的重大信息,公司会严格按照相关法律法规履行信息披露义务。同时,提醒各位 投资者以公司在法定渠道披露的公告为准,理性投资,注意风险。 ...
美邦股份龙虎榜数据(12月16日)
Zheng Quan Shi Bao Wang· 2025-12-16 10:00
资金流向方面,今日该股主力资金净流出4507.25万元,其中,特大单净流入683.29万元,大单资金净流 出5190.53万元。近5日主力资金净流出2654.21万元。 10月29日公司发布的三季报数据显示,前三季度公司共实现营业收入6.09亿元,同比下降2.23%,实现 净利润3619.61万元,同比下降16.36%。(数据宝) 美邦股份(605033)今日下跌8.08%,全天换手率11.31%,成交额3.56亿元,振幅18.99%。龙虎榜数据显 示,营业部席位合计净卖出2644.18万元。 上交所公开信息显示,当日该股因日振幅值达18.99%上榜,营业部席位合计净卖出2644.18万元。 证券时报·数据宝统计显示,上榜的前五大买卖营业部合计成交9488.59万元,其中,买入成交额为 3422.21万元,卖出成交额为6066.39万元,合计净卖出2644.18万元。 具体来看,今日上榜营业部中,第一大买入营业部为麦高证券有限责任公司北京分公司,买入金额为 914.79万元,第一大卖出营业部为国泰海通证券股份有限公司无锡人民中路证券营业部,卖出金额为 1353.76万元。 近半年该股累计上榜龙虎榜5次,上榜次 ...
农化制品板块12月16日跌1.22%,美邦股份领跌,主力资金净流出5.49亿元
Zheng Xing Xing Ye Ri Bao· 2025-12-16 09:10
从资金流向上来看,当日农化制品板块主力资金净流出5.49亿元,游资资金净流入1.95亿元,散户资金 净流入3.54亿元。农化制品板块个股资金流向见下表: 证券之星消息,12月16日农化制品板块较上一交易日下跌1.22%,美邦股份领跌。当日上证指数报收于 3824.81,下跌1.11%。深证成指报收于12914.67,下跌1.51%。农化制品板块个股涨跌见下表: 以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。 ...
分红早知道|最近24小时内,美邦股份、顶点软件、通行宝、陆家嘴等11家A股上市公司发布分红派息实施公告!
Mei Ri Jing Ji Xin Wen· 2025-12-02 08:52
Group 1: Dividend Indices - The Low Volatility Dividend Index (H30269.CSI) includes 50 securities with good liquidity, continuous dividends, moderate payout ratios, positive growth in dividends per share, high dividend yields, and low volatility, with a one-year dividend yield of 4.09% as of December 1 [1] - The Dividend Quality Index (931468.CSI) consists of 50 securities that continuously pay cash dividends, have high payout ratios, and exhibit high profitability, with a one-year dividend yield of 3.42% as of December 1 [1] Group 2: Company Dividend Announcements - Tongxingbao announced a cash dividend of 1.50 RMB per 10 shares (tax included), with a record date of December 5, 2025, and an ex-dividend date of December 8, 2025 [1] - Shanghai Ailu announced a cash dividend of 0.40 RMB per 10 shares (tax included), with a record date of December 4, 2025, and an ex-dividend date of December 5, 2025 [2] - Aiwei Technology announced a cash dividend of 0.054 RMB per share (tax included), with a record date of December 5, 2025, and an ex-dividend date of December 8, 2025 [2] - Meibang Co. announced a cash dividend of 0.05 RMB per share (tax included), with a record date of December 9, 2025, and an ex-dividend date of December 10, 2025 [2] - Aidi Precision announced a cash dividend of 0.10 RMB per share (tax included), with a record date of December 5, 2025, and an ex-dividend date of December 8, 2025 [3] - Dingdian Software announced a cash dividend of 0.20 RMB per share (tax included), with a record date of December 9, 2025, and an ex-dividend date of December 10, 2025 [3] - Jingjin Equipment announced a cash dividend of 0.50 RMB per share (tax included), with a record date of December 5, 2025, and an ex-dividend date of December 8, 2025 [3] - Lujiazui announced a cash dividend of 0.0633 RMB per share (tax included), with a record date of December 9, 2025, and an ex-dividend date of December 10, 2025 [4] - Zhongzhi Technology announced a cash dividend of 0.80 RMB per 10 shares (tax included), with a record date of December 5, 2025, and an ex-dividend date of December 8, 2025 [4] - Dahua Co. announced a cash dividend of 1.850000 RMB per 10 shares (tax included), with a record date of December 8, 2025, and an ex-dividend date of December 9, 2025 [4] - Sun Paper announced a cash dividend of 1.00 RMB per 10 shares (tax included), with a record date of December 9, 2025, and an ex-dividend date of December 10, 2025 [5]
美邦股份(605033) - 陕西美邦药业集团股份有限公司关于使用暂时闲置募集资金进行现金管理到期赎回的公告
2025-12-01 10:15
证券代码:605033 证券简称:美邦股份 公告编号:2025-055 陕西美邦药业集团股份有限公司 关于使用暂时闲置募集资金进行现金管理到期赎回的公告 2025 年 6 月,公司以闲置募集资金 1500.00 万元购买理财产品,具体内容详 见公司于 2025 年 6 月 18 日披露在上海证券交易所网站(www.sse.com.cn)的《陕 西美邦药业集团股份有限公司关于使用暂时闲置募集资金进行现金管理到期赎 回并继续进行现金管理的公告》(公告编号:2025-033)。本次赎回产品的基本 情况如下: 单位:万元 | 受托 | 产品 | 产品 | 金额 | 实际 | 起息日 | 到期日 | 赎回金 | 实际 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 方名 | 类型 | 名称 | (万元) | 收益率 | | | 额 | 收益 | | 称 | | | | | | | | | | | | 安盈象固收 | | | | | | | | 中信银 | 银行理 | 稳利一个月 | 1,500 | 1.57% | 2025-6-17 | 2025- ...
美邦股份(605033) - 陕西美邦药业集团股份有限公司2025年前三季度权益分派实施公告
2025-12-01 10:15
证券代码:605033 证券简称:美邦股份 公告编号:2025-056 陕西美邦药业集团股份有限公司 2025年前三季度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 一、 通过分配方案的股东会届次和日期 本次利润分配方案经陕西美邦药业集团股份有限公司(以下简称"公司")2025 年 5 月 16 日的2024年年度股东会授权,2025 年 10 月 28 日召开的第三届董事会第九次会议审议通 过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后,在中国证券登记结算有限责任公司上海分 公司(以下简称"中国结算上海分公司")登记在册的本公司全体股东。 每股分配比例 A 股每股现金红利0.05元 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权(息)日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | A股 | 2025/12/9 | - | 2025/12/10 | 2025/12/10 | 差异化分红送转: 否 3. 分配方案: ...
美邦股份:1500万元闲置募集资金现金管理到期赎回,获收益10.74万元
2 1 Shi Ji Jing Ji Bao Dao· 2025-12-01 09:53
南财智讯12月1日电,美邦股份公告,公司于2025年11月27日赎回中信银行"安盈象固收稳利一个月持有 期32号C"理财产品,收回本金1500.00万元,并收到理财收益10.74万元。上述资金已划至募集资金专用 账户。本次现金管理到期赎回不会影响募集资金投资项目进度和公司正常生产经营。公司再以闲置募集 资金继续进行现金管理。 ...
美邦股份在印度尼西亚成功获批五个原药登记证
Zheng Quan Shi Bao Wang· 2025-12-01 00:57
Core Viewpoint - Meibang Co., Ltd. has made significant progress in the Indonesian market by obtaining five drug registration certificates, enhancing its presence in Southeast Asia [1] Group 1 - Meibang Co., Ltd. has received approval for five original drug registration certificates in Indonesia [1] - The company is actively registering multiple products in Indonesia, with expectations for more approvals in the next two years [1]
研判2025!中国芸苔素内酯行业政策汇总、产业链、发展现状、竞争格局及未来趋势分析:绿色农药政策加码,芸苔素内酯成作物健康与增产新动力[图]
Chan Ye Xin Xi Wang· 2025-11-04 01:12
Core Viewpoint - The growth regulator, brassinosteroid, is gaining traction in the agricultural sector due to national green pesticide policies, with its market size expected to reach 1.5 billion yuan in 2024 and exceed 2 billion yuan by 2030 [1][10]. Industry Overview - Brassinosteroid, with the chemical formula C28H48O6, is a new type of green and environmentally friendly plant growth regulator, widely present in plants and known for its high biological activity [3]. - It promotes the growth of various crops, improves quality, and increases yield, making it popular among farmers, especially in the production of economic crops like fruits, vegetables, and flowers, as well as major crops like rice, wheat, and corn [1][10]. Industry Policies - The market for brassinosteroid is gaining attention due to its high efficiency, broad spectrum, and safety features, which align with the increasing focus on food security and green agriculture policies [5][6]. - Recent policies, such as the implementation of the "14th Five-Year Plan" for agricultural green development, emphasize the safe and efficient application of plant growth regulators [12]. Industry Chain - The brassinosteroid industry chain includes upstream components like steroid compounds and solvents, midstream production, and downstream applications in agriculture, horticulture, and forestry [7]. - The total sown area of crops in China is projected to grow from 165.9 million hectares in 2018 to 173 million hectares in 2024, with a compound annual growth rate of 0.7%, driving the demand for pesticides, including brassinosteroid [7]. Current Industry Status - The pesticide industry in China has developed a complete industrial system, becoming the largest pesticide producer globally. The production of chemical pesticide raw materials is expected to increase significantly due to supportive national policies and product structure optimization [8][9]. - In 2024, the production of chemical pesticide raw materials is projected to reach 3.675 million tons, a year-on-year increase of 37.6% [9]. Competitive Landscape - The brassinosteroid market in China is becoming increasingly competitive, with a growing number of companies entering the sector, including Meibang Co., Ltd. and *ST Huifeng [2][10]. - Companies like Yunnan Yunda Technology Agricultural Chemical Co., Ltd. are focusing on research and development of brassinosteroid products, contributing to the industry's growth [11]. Industry Development Trends - The market for brassinosteroid is expected to expand due to increased support for green agriculture and rising consumer demands for high-quality agricultural products [12]. - The industry is witnessing a trend towards consolidation, with smaller companies facing challenges, while those with advantages in technology and market promotion are likely to thrive [13]. - The development of long-lasting brassinosteroid products is becoming a key focus, supported by advancements in technologies that enhance the effectiveness and duration of these products [14].
机构风向标 | 美邦股份(605033)2025年三季度已披露前十大机构持股比例合计下跌1.41个百分点
Xin Lang Cai Jing· 2025-10-29 03:00
Group 1 - The core point of the news is that Meibang Co., Ltd. (605033.SH) reported its Q3 2025 results, revealing a total of 16.0152 million A-shares held by four institutional investors, accounting for 11.85% of the total share capital, which is a decrease of 1.41 percentage points from the previous quarter [1] - Institutional investors include Lianyungang Tongmei Enterprise Management Co., Ltd., Lianyungang Meifu Enterprise Management Consulting Partnership (Limited Partnership), Lianyungang Meiping Enterprise Management Consulting Partnership (Limited Partnership), and UBS AG [1] - Three public funds were disclosed this period, including Nuoan Innovation-Driven Mixed A, Jiaoyin Trend Mixed A, and Xinhua Xin Technology 3-Month Rolling Flexible Allocation Mixed A, which were not reported in the previous quarter [1] Group 2 - One new foreign institution, UBS AG, was disclosed this period, while BARCLAYS BANK PLC was not reported in the current quarter [1]